lines were treated with DMSO control or PMA (100 nM) for 10 min. Cells were lysed, endogenous PIP5K1C was immunoprecipitated (anti-PIP5K1C), and immunoprecipitates were analyzed by SDS-PAGE and immunoblotting for phosphorylation of PIP5K1C at S448 (anti-pS448-PIP5K1C, A) or at S650 (anti-pS650-PIP5K1C, B). Samples were re-probed for total PIP5K1C. (C) MCF-7 cells were transfected with tagged constitutively-active versions of PKD1, PKD2 or PKD3 together with HA-tagged PIP5K1C. Cells were lysed, overexpressed PIP5K1C was immunoprecipitated (anti-HA), and immunoprecipitates were analyzed by SDS-PAGE and immunoblotting for phosphorylation of PIP5K1C at S650 (anti-pS650-PIP5K1C). Samples were re-probed for total PIP5K1C by staining with anti-HA. In addition expression of active PKD isoforms was determined by Western blotting of lysates with TAG-specific antibodies as indicated.
